Head Organoid Phenotyping
Roche, Basel-Stadt, Switzerland
Marc Bickle obtained his PhD at the Biozentrum in Basel, Switzerland, studying the immunosuppressive drug Rapamycin. He then went to the Laboratory of Molecular Biology (LMB) in Cambridge, UK, to study the genetics of behavior in C. elegans. He then participated in the creation of Aptanomics, a drug discovery Biotech in Lyon, France, developing yeast 2 hybrid screens to select collection of peptide aptamers. After this period in biotechnology he headed the High Content Screening facility at the Max Planck Institute of Molecular Cell Biology and Genetic (MPI-CBG) in Dresden, Germany, performing functional genomic and chemical screens using automated microscopy. Since 2021, Marc is leading the Organoid Phenotyping platform at the Institute for Human Biology at pRed, Roche in Basel Switzerland.
Disclosure information not submitted.
Sunday, February 6, 2022
8:30 AM – 4:30 PM
Tuesday, February 8, 2022
3:00 PM – 4:00 PM